aynaud
jm
bernard
bottreau
e
lantier
salmon
h
vannier
ph
induct
lactogen
immun
transmiss
gastroenter
viru
swine
use
attenu
coronaviru
mutant
abl
surviv
physicochem
environ
digest
tract
vet
microbiol
transmiss
gastroenter
tge
coronaviru
mutant
select
attenu
resist
acid
proteas
digest
tract
adult
pig
use
vaccin
nouzilli
strain
sow
protect
suckl
piglet
challeng
exposur
carri
highli
virul
tgev
strain
pregnant
sow
immun
day
farrow
twice
day
farrow
oral
intramuscular
conjunctiv
rout
strain
sow
expos
virul
tgev
field
experiment
infect
sow
two
oral
inocul
pregnanc
use
posit
control
lead
high
protect
neutral
antibodi
respons
vaccin
andor
infect
studi
serum
milk
protect
mortal
observ
litter
nine
seroneg
suscept
sow
piglet
mortal
seven
oral
vaccin
sow
mortal
seven
sow
vaccin
twice
conjunctiv
rout
mortal
moder
protect
observ
eight
sow
vaccin
intramuscularli
twice
piglet
mortal
seven
oral
intramuscularli
vaccin
sow
piglet
mortal
contrast
improv
protect
observ
sow
vaccin
twice
oral
piglet
mortal
four
natur
infect
sow
piglet
mortal
six
sow
experiment
infect
virul
tgev
piglet
mortal
correl
found
neutral
antibodi
titer
serum
milk
protect
rate
piglet
result
indic
rel
protect
lactogen
immun
tgev
induc
repeat
ingest
attenu
strain
tgev
transmiss
gastroenter
tge
swine
highli
contagi
enter
viral
diseas
pig
week
age
well
establish
sow
recov
tge
abl
transmit
protect
immun
suckl
pig
hooper
halterman
bohl
et
al
neutral
tge
viru
tgev
lumen
gut
newborn
antibodi
continu
suppli
colostrum
milk
immun
sow
believ
provid
passiv
protect
suckl
piglet
numer
tgev
vaccin
evalu
efficaci
question
hen
thoma
bohl
et
al
bohl
moxley
olson
attenu
tgev
live
vaccin
fail
initi
gut
mammari
gland
immun
respons
essenti
provid
optim
immun
salmon
low
stabil
cell
cultur
adapt
tgev
strain
gastric
gut
juic
laud
et
al
aynaud
bottreau
may
destroy
viru
transit
gut
probabl
respons
failur
oral
vaccin
use
survivor
select
process
gastric
juic
select
attenu
mutant
tgev
surviv
physicochem
environ
digest
tract
adult
pig
aynaud
et
al
preliminari
experi
carri
limit
number
sow
indic
new
tgev
mutant
capabl
induc
protect
lactogen
immun
could
consid
candid
oral
tgev
vaccin
aynaud
et
al
purpos
present
work
studi
lactogen
immun
afford
suckl
piglet
sow
immun
new
mutant
use
oral
intramuscular
conjunctiv
rout
passiv
protect
assay
exposur
piglet
standard
challeng
dose
fulli
virul
tgev
antibodi
respons
evalu
titrat
neutral
activ
serum
milk
collect
immun
sow
time
challeng
exposur
rpd
pig
kidney
cell
line
previous
describ
laud
et
al
mcclurkin
swine
testi
st
cell
line
suppli
eh
bohl
wooster
ohio
usa
minimum
essenti
medium
mem
supplement
fetal
calf
serum
use
cell
growth
strain
tgev
attenu
mutant
obtain
previous
laboratori
virul
gepii
strain
serial
cycl
survivor
select
gastric
juic
adult
pig
properti
new
tgev
strain
describ
previous
aynaud
bottreau
aynaud
et
al
bernard
et
al
nguyen
et
al
attenu
verifi
five
serial
back
passag
fulli
suscept
neonat
pig
high
passag
strain
tgev
use
seroneutr
test
cell
cultur
produc
rpd
cell
viru
infect
titrat
perform
st
cell
use
plaqu
assay
previous
describ
aynaud
et
al
fulli
virul
gepii
strain
isol
acut
outbreak
franc
describ
elsewher
aynaud
bottreau
aynaud
et
al
bernard
et
al
use
challeng
suckl
piglet
virul
gepii
strain
titrat
piglet
sow
use
studi
largewhit
meishan
bred
fiftyf
obtain
two
tgev
free
herd
seroneg
tgev
four
seroposit
sow
obtain
previous
infect
herd
sow
hous
isol
unit
farrow
includ
post
challeng
period
strain
supernat
rpd
cultur
pfuml
use
vaccin
oral
vaccin
perform
fast
sow
ml
viru
dilut
ml
mcilvain
buffer
ph
immun
rout
viral
suspens
infect
cell
supernar
use
intramuscular
vaccin
ml
administ
eye
conjunctiv
vaccin
gepii
strain
ml
fulli
virul
gepii
strain
dilut
ml
mcilvain
buffer
protocol
immun
first
viru
dose
administ
day
parturit
group
second
viru
dose
booster
administ
day
farrow
passiv
protect
piglet
tgev
virul
challeng
suckl
piglet
nurs
mother
sow
challeng
virul
gepii
strain
oral
rout
ml
day
birth
clinic
sign
mortal
rate
score
follow
day
litter
consid
protect
challeng
piglet
surviv
neutral
antibodi
respons
serum
milk
sow
serum
milk
sampl
collect
differ
period
vaccin
booster
challeng
day
challeng
examin
presenc
nt
antibodi
use
microneutr
test
st
cell
previous
describ
toma
benet
tabl
antibodi
titer
evalu
challeng
time
day
later
shown
immunochem
analysi
antibodi
class
serum
milk
sampl
sow
publish
previous
shira
et
al
total
mortal
rate
sowvaccin
group
taken
account
instead
protect
rate
per
litter
due
need
incorpor
data
without
assumpt
mortal
rate
class
sow
non
protect
protect
group
comparison
rout
immun
made
case
differ
comparison
two
group
done
clinic
respons
observ
sow
follow
vaccin
follow
virul
infect
gep
ii
strain
sow
exhibit
clinic
reaction
litter
control
sow
seroneg
suscept
ss
sow
tabl
piglet
nurs
ss
sow
exhibit
acut
clinic
sign
vomit
diarrhea
dehydr
h
challeng
exposur
death
occur
day
sixtyf
control
piglet
die
mortal
rate
group
use
elisa
tgev
could
shown
diarrheic
faec
bernard
et
al
tabl
studi
conduct
sow
herd
natur
infect
tge
month
ago
challeng
exposur
suckl
piglet
morbid
mild
delay
mortal
rate
litter
consid
protect
tabl
immun
gepii
virul
strain
carri
twice
oral
rout
six
pregnant
sow
follow
first
oral
inocul
sow
exhibit
clinic
sign
appetit
depress
diarrhea
challeng
exposur
piglet
two
litter
six
observ
slightli
sick
day
post
exposur
one
piglet
die
result
mortal
rate
litter
protect
oral
prime
without
booster
tabl
seven
sow
vaccin
challeng
exposur
piglet
induc
intens
morbid
among
piglet
mortal
rate
litter
protect
oral
prime
oral
booster
oror
tabl
challeng
exposur
suckl
piglet
litter
delay
clinic
reaction
vari
intens
observ
diarrhea
occur
gener
litter
except
oral
prime
oral
booster
kill
viru
tabl
sow
prime
boost
oral
rout
vaccin
dose
compos
pfu
inactiv
ultraviolet
treatment
administr
challeng
exposur
piglet
litter
die
typic
sign
tge
mortal
two
litter
protect
cinat
twice
conjunctiv
rout
challeng
exposur
piglet
morbid
intens
litter
mortal
rate
high
litter
protect
statist
analysi
chisquar
show
oralor
intramuscularintramuscular
rout
potent
oralintramuscular
conjunctivalconjunctiv
rout
compar
separ
conjunctivalconjunctiv
non
immun
sow
appear
rout
effect
hand
comparison
oralor
intramuscularintramuscular
chisquar
reveal
oralor
potent
intramuscularintramuscular
z
p
whatev
condit
immun
sow
show
seroconvers
demonstr
signific
nt
antibodi
increas
vaccin
tabl
antibodi
titer
observ
time
challeng
serum
milk
sow
similar
except
sow
prime
boost
intramuscular
rout
high
antibodi
titer
seen
serum
low
titer
milk
compar
antibodi
level
challeng
exposur
piglet
ni
ei
sow
show
milk
antibodi
titer
equal
higher
serum
convers
whatev
immun
procedur
vaccin
sow
show
compar
situat
serum
milk
challeng
exposur
antibodi
titer
increas
exclus
vaccin
sow
thu
sow
vaccin
sow
exhibit
signific
anamnest
antibodi
respons
tabl
oral
prime
oral
booster
sow
tabl
ultraviolet
inactiv
vaccin
nt
antibodi
detect
serum
milk
time
challeng
suggest
multipl
tgev
need
induct
detect
humor
immun
respons
slight
antibodi
increas
observ
serum
sow
also
serum
milk
control
ss
sow
challeng
exposur
suckl
piglet
tabl
suggest
primari
antibodi
respons
virul
tgev
excret
diarrheic
piglet
evalu
passiv
protect
tge
larg
depend
virul
tgev
strain
use
challeng
virul
miller
strain
use
previous
sever
author
bohl
et
al
bohl
et
al
hen
thoma
bohl
saif
moxley
olson
retain
studi
moder
pathogen
observ
experiment
condit
experi
mortal
rate
observ
miller
strain
never
exceed
data
shown
contrast
isol
acut
outbreak
franc
gepii
strain
high
mortal
rate
regularli
obtain
neg
control
experi
present
report
mortal
rate
obtain
suscept
litter
miller
strain
age
piglet
challeng
note
moxley
olson
factor
influenc
mortal
rate
experiment
condit
statist
analysi
carri
litter
challeng
highli
virul
gepii
strain
demonstr
signific
relationship
age
piglet
challeng
mortal
rate
correl
coeffici
p
compar
abil
strain
given
differ
rout
induc
lactogen
protect
consider
variat
among
group
vaccin
sow
regard
mortal
rate
piglet
oral
rout
oralor
rout
evid
booster
immun
essenti
induc
high
protect
oral
rout
prime
booster
also
influenc
induct
high
protect
rate
mortal
similar
observ
among
natur
infect
sow
observ
indic
repeat
oral
administr
vaccin
influenc
develop
tgev
protect
immun
absenc
detect
humor
immun
respons
oral
vaccin
ultraviolet
treat
viru
suggest
also
repeat
antigen
stimul
gut
appropri
replic
antigen
need
optim
induct
passiv
protect
heterogen
immun
respons
among
eight
sow
vaccin
boost
intramuscular
rout
four
litter
well
protect
four
fulli
suscept
similar
observ
report
bohl
saif
intramuscular
inject
pregnant
sow
virul
tgev
postul
author
passiv
protect
strongli
depend
whether
sow
gut
infect
haematogen
spread
viru
possibl
infect
macrophag
laud
et
al
spread
vaccin
viru
gut
mammari
gland
intramuscular
administr
suggest
argu
concept
common
mucos
immun
system
postul
conjunctiv
rout
montgomeri
et
al
use
success
variou
pathogen
fensterbank
et
al
tannock
et
al
kramer
et
al
would
altern
approach
oral
immun
unfortun
ineffici
experi
term
protect
although
vaccin
sow
exhibit
serum
milk
neutral
antibodi
conjunctiv
vaccin
reason
lack
success
unknown
probabl
suggest
conjunctiv
rout
abl
induc
local
antigen
stimul
gut
vaccin
sow
develop
signific
antibodi
titer
serum
milk
whatev
degre
protect
transmit
suckl
piglet
result
confirm
lack
correl
degre
passiv
protect
piglet
level
neutral
antibodi
sow
serum
milk
r
time
challeng
observ
previou
author
bohl
et
al
bohl
sail
moxley
olson
howev
challeng
exposur
vaccin
sow
show
anamnest
antibodi
respons
gener
higher
degre
protect
litter
low
contrast
natur
experiment
infect
sow
fail
show
anamnest
respons
suggest
lack
anamnest
respons
observ
sow
challeng
exposur
piglet
could
consid
posteriori
index
protect
lactogen
immun
present
result
confirm
previou
preliminari
observ
aynaud
et
al
shira
et
al
furthermor
sensit
immunochem
approach
elisa
immunoadsorb
use
iga
antibodi
detect
time
challeng
milk
experiment
infect
sow
also
milk
oral
vaccin
booster
sow
contrast
infect
sow
iga
antibodi
level
never
predomin
milk
vaccin
sow
suggest
mechan
involv
tge
lactogen
immun
induc
attenu
strain
could
differ
virul
tgev
strain
bohl
et
al
strain
induc
complet
protect
lactogen
immun
compar
natur
experiment
virul
infect
morbid
frequent
observ
surviv
litter
nevertheless
result
suggest
oral
immun
pregnant
sow
new
strain
success
comparison
previou
attenu
tge
vaccin
limit
effect
hen
thoma
bohl
et
al
bohl
moxley
olson
protect
immun
induc
vaccin
strain
could
partli
explain
higher
stabil
strain
physicochem
environ
digest
tract
sow
allow
viru
reach
suscept
site
gut
high
content
structur
antigen
compar
bernard
et
al
nguyen
et
al
ambico
strain
data
shown
allow
viru
surviv
inactiv
digest
proteas
exact
mechan
lead
induct
protect
immun
follow
immun
strain
still
unknown
strain
character
differ
vitro
properti
resist
acid
proteas
higher
content
structur
antigen
delay
viral
multipl
aynaud
et
al
nguyen
et
al
possibl
repercuss
condit
viru
multipl
also
present
viral
antigen
surfac
infect
enterocyt
amount
appropri
antigen
produc
gut
epitheli
cell
process
antigen
present
cell
would
perhap
crucial
factor
mainli
involv
induct
optim
local
immun
respons
develop
tgev
lactogen
immun
better
knowledg
field
analysi
milk
immun
factor
connect
protect
without
doubt
key
improv
tgev
immun
whatev
type
vaccin
